...
首页> 外文期刊>Current medical research and opinion >Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data
【24h】

Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

机译:长效可注射抗精神病药治疗的早期开始与精神分裂症患者的住院率和医疗费用降低:来自美国声称数据的现实世界证据

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Early initiation of antipsychotic treatment in schizophrenia is associated with improved outcomes. This study aimed to determine if initiation of long-acting injectable (LAI) antipsychotic treatment early in a new schizophrenia episode is associated with lower hospitalization rates and healthcare costs in a real-world setting.Methods: This retrospective (January 1, 2007-June 30, 2016) cohort analysis used claims from Truven Health Analytics MarketScan Commercial, Medicaid, and Medicare Supplemental databases. In adults 18years with a new episode of schizophrenia, two mutually exclusive cohorts were identified based on time from first recorded schizophrenia diagnosis date to first date of LAI initiation (index date): 1year (early initiators) and >1year (late initiators). Logistic and general linear regression models were performed to estimate adjusted hospitalization rate and healthcare costs in a 1-year follow-up, controlling patient demographic and clinical characteristics, insurance type, baseline all-cause hospitalizations and ED visits, and baseline psychiatric medication use.Results: Of the subjects, 32% (n=1388) initiated treatment early and 68% (n=2978) initiated treatment later. In risk-adjusted models, all-cause hospitalization rates were 22.2% (95% CI=19.9-24.6%) in early initiators and 26.9% (95% CI=25.2-28.7%) in late initiators (p=.002). Of early initiators, 14.1% (95% CI=12.3-16.1%) had a psychiatric hospitalization vs 19.2% (95% CI=17.7-20.8%) of late initiators (p<.001). Adjusted psychiatric healthcare costs were significantly lower in early initiators compared with late initiators [mean (95% CI)=$21,545 (20,355-22,734) vs $24,132 (23,330-24,933)] (p<.001).Conclusions: LAI initiation within 1 year of a new schizophrenia episode led to lower hospitalization rates and healthcare costs compared with LAI initiation more than 1 year after a new episode.
机译:目的:精神分裂症中抗精神病药治疗的早期发酵与改善的结果有关。本研究旨在确定在新的精神分裂症发作早期的长效可注射(LAI)抗精神病药治疗的启动与现实世界的环境中的住院率和医疗费用较低,方法:这项回顾性(2007年1月1日 - 6月1日) 30日,2016年)队列分析来自Truven Health Inalytics Marketscan商业,医疗补助和Medicare补充数据库的索赔。在成年人18年代具有精神分裂症的新集中,根据LAI启动的第一日(指数日期)和> 1年(晚期启动人士)和> 1年(晚期启动人士)和> 1年(晚期启动人士)的第一次录制的精神分裂症诊断日期(索引日期)和> 1年(延迟启动人士)的时间鉴定了两个相互排斥的群组。进行逻辑和一般线性回归模型以在1年的随访中估算调整后的住院率和医疗成本,控制患者人口统计和临床特征,保险类型,基线全因住院和ED访问以及基线精神疗养药物使用。结果:受试者,32%(n = 1388)早期发起治疗,68%(n = 2978)以后启动治疗。在风险调整后的模型中,早期引发剂的全部导致住院率为22.2%(95%CI = 19.9-24.9-24.6%),晚期引发剂中的26.9%(95%CI = 25.2-28.7%)(P = .002)。早期引发剂,14.1%(95%CI = 12.3-16.1%),精神病院治疗与19.2%(95%CI = 17.7-20.8%)晚期引发剂(P <.001)。早期引发剂的调整后精神病医疗费用显着降低,与晚期引发剂相比在一个新的精神分裂症剧集导致率低于新闻发作后1年以上的赖初期的住院率和医疗保健成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号